Management of Acute Native Joint Bacterial Arthritis in Adults in 2020 - A Short Narrative, Practical State-of-the-Art Review by Ansorge, A et al.








Management of Acute Native Joint Bacterial Arthritis in Adults in 2020 - A
Short Narrative, Practical State-of-the-Art Review
Ansorge, A ; Selman, F ; Uçkay, İlker
Abstract: Native joint bacterial arthritis is a common infection among adults and children. A solely
conservative management, without any articular drainage/lavage, increases the risk of recurrence. In
contrast, the type of initial lavage/drainage can be surgical (arthrotomy or arthroscopy) or non-surgical
(iterative arthrocenteses). Up to date, no superiority has been shown for any of these approaches in
relation to recurrence risk and postinfectious mechanical damage. Furthermore, an initial synovectomy,
or the number of iterative drainages does not influence outcome in most cases. Nowadays, an antibiotic
regimen of three to four weeks, with early oral therapy, is standard in most settings of the world. In
arthritis cases involving the hand and wrist, a shorter systemic antibiotic treatment such as two weeks is
sufficient. The outcome of infection is impacted by of mechanical sequelae in up to 40% of cases. These
sequels are predominantly joint stiffness and/or osteoarthritis, which are difficult to treat.
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Native joint bacterial arthritis is a common infection among adults and children. A solely conservative management, without any 
articular drainage/lavage, increases the risk of recurrence. In contrast, the type of initial lavage/drainage can be surgical (arthrotomy 
or arthroscopy) or non-surgical (iterative arthrocenteses). Up to date, no superiority has been shown for any of these approaches in 
relation to recurrence risk and postinfectious mechanical damage. Furthermore, an initial synovectomy, or the number of iterative drainages does not influence outcome in most cases. Nowadays, an antibiotic regimen of three to four weeks, with early oral therapy, 
is standard in most settings of the world. In arthritis cases involving the hand and wrist, a shorter systemic antibiotic treatment such as two weeks is sufficient. The outcome of infection is impacted by of mechanical sequelae in up to 40% of cases. These sequels are predominantly joint stiffness and/or osteoarthritis, which are difficult to treat.
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IntroductionThe clinical appearance of native joint bacterial arthritis are 
very close to those of any non-infectious arthritis, such as viral, 
reactive, crystal-induced, or auto-immune arthritis. Yet, bacterial 
arthritis should be diagnosed and treated early in the process, since 
enzymes liberated by bacterial pathogens or reacting granulocytes 
risk to damage the bradytroph cartilage. Available literature about 
bacterial arthritis is composed of plenty expert opinions and reviews, while original research articles are less frequent [1]. In this narrative 
review, we focus on the current “lege artis” clinical management of 
native joint bacterial arthritis based on available published evidence. 
Epidemiology, origins and causative pathogensThe annual incidence of native joint bacterial arthritis in 
wealthy countries varies between 2-10 cases per 100,000 persons 
[2-4]as well as patient charts with a discharge diagnosis of septic arthritis (International Statistical Classification of Diseases and Re-
lated Health Problems (ICD. Most septic arthritis is monoarticular. Indeed, only 2.7 to 15% present as a polyarticular arthritis [5-10]
the proportion of septic arthritis cases involving people who inject drugs (PWID. The majority of septic arthritis cases occur spontane-
ously or are believed to be secondary to an hematogenous spread 
of bacteria from a skin lesion into the joint [2-4]as well as patient 
charts with a discharge diagnosis of septic arthritis (International Statistical Classification of Diseases and Related Health Problems 
(ICD. Spontaneous infection involves predominantly the major 
weight-bearing joints. Indeed, the knee is affected most of the time, followed in decreasing frequency by the hip, the elbow, the hand, the ankle, the wrist, the sternoclavicular and finally the sacroiliac 
articulations [6]. Globally, Staphylococcus aureus is the most preva-
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lent pathogen in 50-60%, followed by streptococci (16%-17%), gram-negative rods (5%-15%), and anaerobes (<1%) [4,5]clini-
cal pattern and outcome. We reviewed the literature from 1945 to 
2010 with an emphasis on post-traumatic cases. We retrieved 14 large-scale epidemiological surveys without detailed stratification 
regarding the origin of septic arthritis (3,340 episodes. In contrast 
to spontaneous adult cases where Staphylococcus aureus is most 
prevalent, in infants the most encountered bacteria is a gram-nega-
tive rod named Kingella kingae [11]we aimed to contrast the bacte-
riologic epidemiology of osteoarticular infections (OAIs). 
Diagnosis
Acute native joint arthritis usually presents with a swollen 
articulation, local erythema and heat, and worsening arthralgia. 
Most patients are transiently febrile. High fever spikes are uncom-
mon, unless there is a synchronous bacteraemia [12]. One should 
in particular look for indices of remote infections like for instance 
endocarditis, respiratory, urinary tract, sexually-transmitted and skin infections. In sexually-active patients without adequate pro-
tection, Neisseria gonorrhoeae, is still quite prevalent [13]. Risk 
factors such as autoimmune rheumatic disease and intravenous 
drug abuse should also be looked for. Interestingly, patients in-fected with the human immunodeficiency virus don’t have an 
increased risk to develop septic arthritism unless they are con-
comitant intravenous drug abusers [1]. If the detailed anamnesis 
and the general physical exam fail to identify a remote origin of the septic arthritis, we generally don’t recommend to perform 
advanced diagnostic tests to force the recognition of the origin of 
the infection because the antibiotic treatment usually cure it, so 
the expenses for endoscopy and complex radiologic exams can be 
avoided [14]. One should also be aware that septic arthritis may 
coincide with crystalline arthritis [15,16]227 with underlying ar-throplasties and 69 with gout or other crystals in synovial fluid. In such cases, it remains unclear if the crystalline inflammation is 
prejudicial in the acute phase. However, evidence exists in favor of 
the use of anti-crystalline treatment like colchicine in case of an 
acute gout developing just after the drainage of a joint for septic 
arthritis [1]. The gold standard for diagnosing bacterial arthritis is 
the objectivation of an identical pathogen in at least two samples of synovial fluid or intraarticular tissue biopsy, or a clinical arthri-tis associated with synchronous positive blood cultures that aren’t 
considered as contamination. Blood cultures should be performed in case of fever and shivering, considering that 50% of them turn 
positive [2]. 
However, a culture-negative bacterial arthritis may also oc-
cur. Risk factors for culture-negative cases are a low inoculum, a 
prior antibiotic exposure, an inappropriate culture media, fastidi-
ous bacteria, or a prolonged transport time to the laboratory favor 
negative-culture results [17]1167 (43%. A clear-cut definition of culture-negative bacterial arthritis doesn’t exist. It is usually di-
agnosed in cases showing a typical clinical presentation with sug-gestive pathologic synovial fluid laboratory results (granulocyte proportion of >90% and/or leukocyte count over 50’000 cells/ µl), and no intraarticular crystals. Polymerase chain techniques (PCR) shouldn’t be routinely used, because eubacterial PCR is quite ex-pensive and seldom of benefit. Its sensitivity is lower than that of classical culture. Moreover, it doesn’t give clues about antibiotic re-
sistance and in the case of a polymicrobial infection its interpreta-
tion is hazardous [1]. In particular clinical situations suggesting an infection by one of the following pathogens, specific PCR is however 
recommended: Kingella kingae, Brucella spp, Borrelia spp, Coxiella 
burnetii, Neisseria gonorrhoeae, Bartonella henselae, Mycobacteri-
um tuberculosis, or Mycobacterium ulcerans are such examples [1]. Laboratory inflammatory markers can be tested systemically 
(i.e. in the blood) and intraarticularly. High white blood cell counts and C-reactive protein concentrations in the blood serum aren’t 
proving a bacterial origin of an arthritis regardless of the used cut-off. Indeed, these inflammatory markers presumably rather reflect the pathogen’s virulence and the synchronous bacteremia than the 
local intraarticular state [18,19]. Therefore, they are also useless 
in the follow up, concerning decision making about the duration of 
antibiotic treatment or the indication of repeated joint drainage/la-
vage. It is still important to know that serum procalcitonin concen-
tration is often low in the case of a localized septic arthritis lacking systemic inflammatory signs [19,20]. Usually, synovial leukocyte counts and neutrophil proportions are determined. These tests 
must however be interpretated with caution, as no cut-off values 
have been shown to be diagnostic for bacterial arthritis. Concern-
ing synovial leukocyte counts, many experts consider a number of >50,000 cells/µl as predictive for a bacterial arthritis [21]. How-ever, there is equally no consensus about this threshold value and other authors set it for example at >100,000 cells/µl [22]not the surrounding soft tissues. The most common causes of monoarthri-
tis are crystals (i.e., gout and pseudogout. Concerning the neutro-phil proportion in the synovial fluid, a literature review including 
6242 cases showed a three-fold probability for septic arthritis in patients with a neutrophil proportion of >90% in comparison to 
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others [23]prompt identification and treatment of septic arthritis can substantially reduce morbidity and mortality.\nOBJECTIVE: To 
review the accuracy and precision of the clinical evaluation for the diagnosis of nongonococcal bacterial arthritis.\nDATA SOURCES: 
Structured PubMed and EMBASE searches (1966 through January 
2007. In future, other intra-synovial marker tests may appear [24]. 
For instance, research about intraarticular lactic acid dosing is 
warranted [25]as well as in 12 cases of gonococcal arthritis (mean 
27 mg/100 ml.
Classical direct microscopic exams using Gram and acridin-
orange staining have been abandoned by many centers as its cost-benefit analyses are unsatisfying. The low sensitivity of di-rect microscopy isn’t surprising as a low intraarticular inoculum is enough to trigger a significant arthritis. The results of Cunning-
ham., et al. illustrate well the low sensitivity of direct microscopy 
[16]227 with underlying arthroplasties and 69 with gout or other crystals in synovial fluid. In their series of 500 adult patients with suspected septic arthritis, they detected pathogens in only 29% of 
cases. When considering only the culture-positive cases (gold stan-dard), they still yielded a low sensitivity of 37%.
TherapyThe treatment of native joint septic arthritis in adults is mainly based on experts’ opinion and on regional habits, because evi-dence is lacking. As a consequence, the treatments vary among 
many parts of the world. However, it is generally articulating 
around two principles, namely lavage/drainage of the affected 
joint(s) and synchronous systemic antibiotic therapy [18]. Avail-
able evidence suggests a higher recurrence risk if only one of these 
two principles is used for treatment. For instance, a retrospective 
work found a 21-fold increase of the recurrence risk in case of a 
strict conservative antibiotic management without any lavage/
drainage [18]. A strict surgical management with iterative lavages/
drainages is in turn impacted by a higher probability of deformity 
and consecutive osteitis [1].
Drainage
Acute bacterial arthritis is usually considered as an absolute 
emergency, necessitating immediate lavage/drainage of the af-
fected joint. This opinion is relying basically on animal studies, 
while available clinical studies in humans fail to support it [1,23]
caused by autoimmunity, immune complexes, crystals, or cartilage damage, is clinically similar to native septic arthritis. The large mi-
crobiological spectrum of joint infection is one of the particularities 
distinguishing arthritis from other orthopedic infections such as osteomyelitis or implant-related infections. The current literature often defines orthopedic infections as “osteoarticular,” suggesting 
that diagnosis and treatment of bone and joint infection would be 
similar. Septic arthritis, osteomyelitis, and orthopedic implant–as-
sociated infections are different in nature, epidemiology, therapy, and outcome. This chapter underlines the particularities of native 
joint arthritis with an emphasis on diagnosis, epidemiology, treat-
ment, and some prevention aspects before planned joint interven-
tions. Most cases of primary septic arthritis and surgical site infec-
tions (SSIs. For instance, Lauper., et al. retrospectively analyzed the 
long-term outcome of over 200 native joint adult bacterial arthritis 
cases in relation to the delay of surgical drainage since the hospital 
admission [26]requiring drainage within hours, including during 
night, weekend or holiday shifts. However, there are few data sup-
porting the need for the disruption caused by this degree of urgen-cy.\nMETHODS: We performed a retrospective review of all adult 
patients seen in our medical center from 1997-2015 with culture-proven septic arthritis and noted the epidemiology of sequelae, 
and their possible association with a delay in surgical drainage.\nRESULTS: Of 204 septic arthritis episodes, 46 (23%. Interestingly, 
no outcome difference could be shown between a delay of less than 6 hours, 6-12 hours or even exceeding 24 hours. They also found 
a mean span of symptoms of 3 days ahead of hospital admission. 
Another study by Vispo-Seara., et al. found a time lapse between the 
onset of septic arthritis and arthroscopic lavage/drainage of over 
2 weeks as being associated with advanced cartilage damage [27]. 
Balabaud., et al. have found a delay of less than 12 days until surgi-
cal drainage to be associated with healing of knee septic arthritis, 
as compared with a delay of 23 days associated with treatment fail-
ure [28]. 
Current literature indicate that any type of joint drainage is valid. The choice of drainage type is also depending on regional 
practice. While surgeons prefer arthrotomy or arthroscopy for 
drainage, many rheumatologists choose iterative arthrocentesis 
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[1,29-31]. Concerning adult septic arthritis, no randomized clinical 
trials comparing surgical drainage to iterative arthrocentesis are 
available. Only retrospective reports are existing. For instance, Ha-
rada., et al. conducted a ten year retrospective single-center study 
to compare outcomes based on the taken management approach: 
medical (bedside closed-needle joint aspiration) versus surgical 
(arthrotomy/arthroscopy) [29]based on medical versus surgical management.\nMETHODS: A 10-year retrospective single-center 
study was conducted of patients admitted to a tertiary care hos-
pital between January 1, 2006 and December 31, 2015 with a 
diagnosis of SA to compare outcomes based on the management 
approach taken: medical (bedside closed-needle joint aspiration. They evaluated outcomes were: the joint recovery, time to recov-
ery, length of hospital stay, disposition to home versus rehabilita-
tion unit, recurrence of arthritis in the same joint, and mortality. There was no statistically significant difference in long-term out-
comes between the two groups at 12 months. Some surgeons plan 
a second look after the initial surgical drainage/lavage, based ex-
clusively on the intraoperative visual aspect of the joint or on the fact that serum C-reactive protein concentrations aren’t decreas-ing in further follow-up. This attitude isn’t supported by evidence. 
We rather recommend to base the indication for a repeated surgi-
cal drainage according to the global clinical course.
Antibiotic treatment
The spectrum 
Until the susceptibility results are available, the initial empiri-
cal antibiotic therapy in bacterial joint arthritis should cover the most frequent pathogens. After that, the initial regimen should be 
replaced by the narrowest possible spectrum. Methicillin-suscep-
tible Staphylococcus aureus and streptococci should be covered at 
the beginning. In case of posttraumatic arthritis (e.g. bites or splin-
ter injuries), Gram-negative bacteria have to be covered as well. In such cases, empirical intravenous (IV) administration of first- or 
second-generation cephalosporin or aminopenicillin is indicated. If community-acquired MRSA (Methicillin-resistant S. aureus) is 
suspected, vancomycin is indicated; respectively clindamycin or 
daptomycin, if an allergy to β-lactam antibiotics is present [32]. 
According to the expert opinion, empirical therapy starts intra-
venously [1]. All intravenous and the majority of oral antibiotics 
do penetrate enough the synovia and do reach concentrations 
exceeding the minimal inhibitory breakpoints of common patho-
gens [33,34]. In acute virulent arthritis early IV-application makes 
sense, but a switch to moral therapy is possible as soon as the 
clinical course is favorable. All non-beta-lactam antibiotics, as for example cotrimoxazole and quinolones are well-known for their 
good oral synovial bioavailability [35,36]where, for at least the first 2-6 weeks, antibiotics should be administered intravenously, 
is more and more challenged in favor of an oral antibiotic treatment with selected agents from the start. There is no evidence that the 
total duration of antibiotic therapy for more than 4-6 weeks im-
proves outcome, when compared with shorter regimens. Hopefully, 
the future will show randomized trials in the adult population, al-
lowing optimal timing of surgical and medical therapy and spar-
ing of unnecessary prescription, with concomitant development 
of antibiotic resistance. External advice from an expert team with 
combined surgeons and infectious disease physicians may help to 
reduce antibiotic consumption in a cost-effective way.”,”container-
title”:”Current Infectious Disease Reports”,”DOI”:”10.1007/
s11908-012-0286-0”,”ISSN”:”1534-3146”,”issue”:”5”,”journalAb








Beta-lactam antibiotics have a low oral bioavailability and should 
therefore be avoided for the oral route. An intraarticular antibiotic 
administration is not indicated because of its potential cartilage 
toxicity [37]the most frequently used antiseptics are polyhexanide, hydrogen peroxide and taurolidine. The aim of this study was to 
examine the effects of these antiseptics on viability of human chon-
drocytes. Our hypothesis was that antiseptics and supplemental 
irrigation with sodium chloride lavage are less toxic on human 
chondrocytes than treatment with antiseptics only. Primary human 
chondrocytes were isolated and cultured from six donated human 
knee joints. Polyhexanide, hydrogen peroxide or taurolidine were added to the cultures. Toxicity analysis was performed by visualisa-tion of cell structure using light microscopy and LDH activity. The 
determination of vital cells and total cell numbers of chondrocytes 
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treated with antiseptics partly followed by irrigation with sodium 
chloride solution was performed by using Casy Cell-Counter. Light 
microscopic data revealed a defect in cell structure after addition of antiseptics. We showed a significant increase of LDH enzyme 
activity after the treatment with polyhexanide or taurolidine. Af-
ter treatment with antiseptics followed by sodium chloride solu-tion a significant increase of vital and total cell numbers resulted 
in comparison with the chondrocytes that were only treated with antiseptics. The data show that treatment with polyhexanid, hy-
drogen peroxide or taurolidine induces cell death of human chon-droctes in vitro. The application of sodium chloride solution after 
the treatment with polyhexanide and hydrogen peroxide possi-




CID: PMC3193958”,”page”:”1719-1723”,”source”:”PubMed Central”,”title”:”Toxicity of antiseptics against chondrocytes: 







Duration of antimicrobial therapyThe optimal duration of post-drainage systemic antibiotic 
treatment is controversial. Often the indicated therapy might de-
pend on the individual case. Some experts advocate a 3-4 weeks 
IV antibiotic therapy for staphylococci and Gram-negative patho-
gens, a 2-week IV therapy for streptococci, and an IV therapy ex-
ceeding four weeks for immune-compromised patients [2]. Nade., 
et al. recommend a 2 weeks IV therapy for streptococci [38]. Often, an IV therapy is recommended for the first 2 weeks, followed by 
a 2-week oral therapy. Yet, this duration is currently considered 
as excessive for drained, adult native joints infections. Indeed, a total antibiotic treatment duration of 3-4 weeks is sufficient 
[33,39]. The antimicrobial treatment in bacterial hand and wrist 
arthritis is usually very short. Angly., et al. showed that no recur-rence occurred in operated adult finger arthritis after antibiotics 
administered for a median duration of 2 days IV and 17 days orally 
[40]surgical technique, antimicrobial therapy and hand therapy.\nPATIENTS AND METHODS: Data of 31 patients with surgical treat-
ment between 1993 and 2005 were screened and those from 29 
patients with > 1 year of follow-up were retrospectively analyzed. Surgical techniques were debridement, primary, secondary ar-throdesis or temporary joint distraction with external fixation. In 
addition, all patients were treated with antibiotics and hand phys-iotherapy. The median follow-up of the 29 patients was 5.7 years.\nRESULTS: The most frequent cause was work injury (19/29. In 
another study including 101 hand arthritis cases and reporting 
similar outcome, the switch to oral therapy occurred 3-5 days post-operatively, which was recently confirmed in another narrative re-
view [41]. It is not yet clear whether a short course of therapy is 
indicated in adult patients with large joint arthritis. Gjika., et al. re-cently issued a prospective-randomized study questioning the suf-ficient length of antimicrobial therapy in 154 patients with native 
joint bacterial arthritis [42]unblinded, randomised, non-inferiority study comparing either 2 or 4 weeks of antibiotic therapy after sur-
gical drainage of native joint bacterial arthritis in adults. Excluded 
were implant-related infections, episodes without surgical lavage and episodes with a follow-up of less than 2 months.\nRESULTS: 
We enrolled 154 cases: 77 in the 4-week arm and 77 in the 2-week 
arm. Median length of intravenous antibiotic treatment was 1 and 2 days, respectively. The median number of surgical lavages was 1 in both arms. Recurrence of infection was noted in three patients (2%. 
One third of them suffered from medium to large joint infection. This study compared 2 weeks with 4 weeks of systemic targeted antibiotics after surgical drainage. The outcomes showed no differ-
ences regarding clinical remissions, adverse events or mechanical sequels. The median duration of initial IV-therapy was limited to 2 days. These results support the hypothesis that a short course of initial IV antibiotic administration is sufficient to treat adult native 
joint arthritis, similarly to other publications reporting pediatric 
cases [39]. 
Outcomes
Primary bacterial native joint arthritis is exceptionally fatal. If it 
is so, usually a severe underlying remote origin, such as endocar-
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to gather data for a prospective study on an optimized antibiotic treatment in adults with septic arthritis.\nMETHODS: This was a 
retrospective single-center study conducted for the period 1996-2008.\nRESULTS: A total of 169 episodes of septic arthritis in 157 
adult patients (median age 63 years; 65 females. In contrast to 
the good infection control after eventually several drainages, the mechanical consequences are of major concern. Prospective ran-domized trials in adults with septic arthritis reported a frequency of mechanical sequels between 20% and 35%, of which 15% re-quired further surgical intervention [26]requiring drainage within 
hours, including during night, weekend or holiday shifts. However, 
there are few data supporting the need for the disruption caused by this degree of urgency.\nMETHODS: We performed a retrospec-
tive review of all adult patients seen in our medical center from 
1997-2015 with culture-proven septic arthritis and noted the epidemiology of sequelae, and their possible association with a delay in surgical drainage.\nRESULTS: Of 204 septic arthritis epi-sodes, 46 (23%. Currently efforts are done to try to treat them by 
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Conclusion
Native joint bacterial arthritis is common. An articular drain-
age/lavage (arthrotomy or arthroscopy, or iterative arthrocentesis 
is always warranted. Up to date, no superiority has been shown for 
any of these approaches in relation to recurrence risk and postin-
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of three to four weeks, with early oral therapy, is standard. In ar-
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